Skip to main content
. Author manuscript; available in PMC: 2009 May 26.
Published in final edited form as: Clin Cancer Res. 2008 Jun 1;14(11):3401–3407. doi: 10.1158/1078-0432.CCR-07-1842

Table 3.

Comparison of staining intensity and percentage of melanoma cells stained with HMW-MAA and MART-1 mAbs

A. In nodal macrometastases*
Staining intensity HMW-MAA MART-1
Strong (+++) 11 (21%) 1 (2%)
Intermediate (++) 28 (54%) 20 (38%)
Weak (+) 13 (25%) 22 (42%)
Negative (−) 0 (0%) 9 (17%)
B. Comparison of the percentage of melanoma cells stained in nodal macrometastases§
Melanoma cells (%) HMW-MAA MART-1

100 23|| (44%) 12 (23%)
99–75 17 (33%) 7 (13%)
74–50 7 (13%) 9 (17%)
49–25 2 (4%) 8 (15%)
24–1 3 (6%) 7 (13%)
0 (negative) 0 (0) 9 (17%)
>50% 47 (90%) 28 (54%)
C. Comparison of the staining intensity of melanoma cells stained in nodal micrometastases
Staining intensity HMW-MAA MART-1

Strong (+++) 5** 3 (9%)
Intermediate (++) 19 (59%) 13 (41%)
Weak (+) 8 (25%) 6 (19%)
Negative (−) 0 10 (31%)
D. Comparison of the percentage of melanoma cells stained in nodal micrometastases††
Melanoma Cells (%) HMW-MAA MART-1

100 9‡‡ (28%) 3 (9%)
99–75 12 (38%) 7 (22%)
74–50 8 (25%) 6 (19%)
49–25 2 (6%) 4 (13%)
24–1 1 (3%) 2 (6%)
0 (negative) 0 10 (31%)§§
>50 29 (91%) 16 (50%)
*

n = 52 Nodes were analyzed.

Number of nodes with the indicated phenotype.

P < 0.0001.

§

n = 52 (SLN and non-SLN) were analyzed.

||

Number of nodes with the indicated phenotype.

n = 32 SLNs were analyzed.

**

Number of nodes with the indicated phenotype.

††

n = 32 SLNs were analyzed.

‡‡

Number of nodes with the indicated phenotype.

§§

P = 0.004.